BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  ACADIA Pharmaceuticals Announces Appointment of Damien McDevitt, Ph.D., as Senior Vice President, Corporate Development

  He will report to Steve Davis, ACADIA’s President and Chief Executive Officer.

  December 13, 2017

   · 

  7 min read
• Policy

  IRRAS Issues Voluntary Recall on Its Irraflow Device

  IRRAS is now working with the battery supplier to understand the specific cause for the failure of the battery.

  December 13, 2017

   · 

  3 min read
• Business

  GW Pharma, Otsuka Satvex Deal Terminated

  As a result, GW has now reacquired full ownership of the development and commercialization rights to the product in the U.S. market.

  December 13, 2017

   · 

  4 min read
• Pharm Country

  Roswell Park Research Suggests New Strategy for Unleashing Cancer-Fighting Power of P53 Gene Study in Nature Communications Also Adds Weight to Evidence That Antioxidants Can Hamper Chemotherapy

  Roswell Park Cancer Institute reports their discovery of a major mechanism by which cells regulate this important and multifunctional tumor suppressor, opening up new avenues for cancer research and treatment.

  December 13, 2017

   · 

  2 min read
• Pharm Country

  Brain & Behavior Research Foundation Awards Distinguished Investigator Grants Valued at $1.7M to 17 Scientists Pursuing Innovative Mental Health Research

  Recipients of the $100,000, one-year grants are seeking new potential targets for understanding and treating a wide range of neuropsychiatric disorders that affect one in five people, including depression, PTSD, eating disorders, schizophrenia, and psychosis.

  December 13, 2017

   · 

  11 min read
• Business

  Xbrane Biopharma Informs About Changes in Management Team

  Carlo Colombo, Head of Production within Xbranes long acting injectable business, has resigned.

  December 13, 2017

   · 

  1 min read
• Pharm Country

  Marinus Pharmaceuticals Added to NASDAQ Biotechnology Index

  This will become effective prior to the open of U.S. markets Monday, December 18, 2017.

  December 13, 2017

   · 

  3 min read
• Pharm Country

  Strongbridge Biopharma plc Added to the NASDAQ Biotech Index

  This will will become effective prior to market open on Monday, December 18, 2017.

  December 13, 2017

   · 

  3 min read
• Eurocine Vaccines Challenges the Flu

  While Australia has faced one of the harshest influenza seasons of decades, Eurocine Vaccines prepares for the next phase of development, a second clinical study with its first vaccine candidate Immunose FLU, to fight the same.

  December 13, 2017

   · 

  3 min read
• SCRA Announces SC Launch Investment in Phi Life Sciences

  SCRA’s entrepreneurial program, SC Launch, Inc., recently finalized a $200,000 investment in Charleston-based Phi Life Sciences.

  December 13, 2017

   · 

  1 min read